Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Efficacy and Safety of Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent Pain

ClinicalTrials.gov ID: NCT00365898

Public ClinicalTrials.gov record NCT00365898. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study of the Efficacy and Safety of 8 Mg Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent Pain

Study identification

NCT ID
NCT00365898
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Purdue Pharma LP
Industry
Enrollment
380 participants

Conditions and interventions

Interventions

  • Hydromorphone Hydrochloride Extended-Release Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2005
Primary completion
Not listed
Completion
Jun 30, 2005
Last update posted
Aug 17, 2006

2005

United States locations

U.S. sites
14
U.S. states
5
U.S. cities
14
Facility City State ZIP Site status
Arizona Research Center 2525 W. Greenway Rd. Suite 114 Phoenix Arizona 85023
Clinical Research of West Florida, Inc. 2147 NE Coachman Road Clearwater Florida 33765
LCFP, Inc. 12631 World Plaza Lane Building 54 Fort Myers Florida 33907
Pharmaceutical Research Associates 1395 N. Courtenay Pkwy Merritt Island Florida 33161
Stedman Clinical Trials 3212 Cove Bend Drive Tampa Florida 33613
Palm Beach Research Center 1897 Palm Beach Lakes Blvd. West Palm Beach Florida 33409
Gold Coast Research 2965 Surrey Lane Weston Florida 33331
PharmQuest 301 E Wendover Avenue Suite 411 Greensboro North Carolina 27401
Hightop Medical Research Center 6103 Hamilton Anenue Cincinnati Ohio 45224
Research Institute of Greater Dayton 1010 Woodman Drive Dayton Ohio 45432
Pharmacotherapy Research Associates, Inc. 3620 Court Drive Zanesville Ohio 43701
Allegheny Pain Management-PC 1402 Ninth Ave Altoona Pennsylvania 16602
he Tipton Medical & Diagnostic Center #334 Route 220 Tipton Pennsylvania 16684
Preferred Primary Care Physicians 202 Jacob Murphy Lane Uniontown Pennsylvania 15401

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00365898, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 17, 2006 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00365898 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →